FDA recall, , Moderate risk
Taro Children's Ibuprofen Oral Suspension
Children's Ibuprofen Oral Suspension contains a gel-like mass and black particles.
Summary by Recall Canary from the FDA notice
What happened
STRIDES PHARMA INC, of Bridgewater, New Jersey, recalled Children's Ibuprofen Oral Suspension, USP, 100 mg per 5mL, 4 FL OZ (120 mL) bottle, manufactured for Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, Made in India, due to the presence of a foreign substance. The firm received complaints for a gel-like mass and black particles in the product. The recall began on March 2, 2026, and was added to the FDA's Enforcement Report on March 16, 2026.
The recalled product was distributed nationwide in the U.S.A.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Match the NDC and lot code listed under your product.
An NDC (National Drug Code) is usually printed on the drug's label.
- NDC
- 51672-5321-8
- Lot code
- 7261973A
- 7261974A
Recall details
- Company began the recall
- Sold in
U.S.A. Nationwide
- Company
- STRIDES PHARMA INCBridgewater, New Jersey
- Hazard
- Foreign object
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 98508
- Recall number
- D-0390-2026
- Quantity recalled
- 89592 bottles
All recalls from STRIDES PHARMA INC
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA
In FDA's weekly enforcement report
Listed on Recall Canary
Summary updated
